Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Jablons

Showing results (161-170 of 197) with videos related to

Pageof 20
Sort By:
Cancers|July 29, 2025
Correction: Hung et al. Cul4A Modulates Invasion and Metastasis of Lung Cancer through Regulation of ANXA10. <i>Cancers</i> 2019, <i>11</i>, 618Ming-Szu Hung, Yi-Chuan Chen, Paul-Yann Lin, et al.
Journal of Cellular and Molecular Medicine|March 26, 2018
Inhibition of yes-associated protein down-regulates PD-L1 (CD274) expression in human malignant pleural mesotheliomaPing-Chih Hsu, Jinbai Miao, Yu-Cheng Wang, et al.
Oncotarget|January 30, 2016
Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomasHio Chung Kang, Hong Kwan Kim, Sharon Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancerDavid H Johnson, Louis Fehrenbacher, William F Novotny, et al.
Oncotarget|July 14, 2016
YAP promotes erlotinib resistance in human non-small cell lung cancer cellsPing-Chih Hsu, Bin You, Yi-Lin Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2023
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung CancerDavid H Johnson, Louis Fehrenbacher, William F Novotny, et al.
Journal of Clinical Pathology|May 10, 2012
The expression of Dishevelled-3 and glutamine metabolism in malignant pleural mesotheliomaTong Li, Sheng-Cai Hou, Jian-Hua Mao, et al.
Journal of Cellular and Molecular Medicine|March 26, 2018
Inhibition of yes-associated protein suppresses brain metastasis of human lung adenocarcinoma in a murine modelPing-Chih Hsu, Jinbai Miao, Zhen Huang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 26, 2014
CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cellsShulin Zhang, Yi-Lin Yang, Yucheng Wang, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 1, 2013
Analytical validation of a practical molecular assay prognostic of survival in nonsquamous non-small cell lung cancerJohannes R Kratz, Patrick T Tham, Michael S Mulvihill, et al.
Pageof 20

Showing results (161-170 of 197) with videos related to

Sort By:
Pageof 20
Cancers|July 29, 2025
Correction: Hung et al. Cul4A Modulates Invasion and Metastasis of Lung Cancer through Regulation of ANXA10. <i>Cancers</i> 2019, <i>11</i>, 618Ming-Szu Hung, Yi-Chuan Chen, Paul-Yann Lin, et al.
Journal of Cellular and Molecular Medicine|March 26, 2018
Inhibition of yes-associated protein down-regulates PD-L1 (CD274) expression in human malignant pleural mesotheliomaPing-Chih Hsu, Jinbai Miao, Yu-Cheng Wang, et al.
Oncotarget|January 30, 2016
Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomasHio Chung Kang, Hong Kwan Kim, Sharon Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancerDavid H Johnson, Louis Fehrenbacher, William F Novotny, et al.
Oncotarget|July 14, 2016
YAP promotes erlotinib resistance in human non-small cell lung cancer cellsPing-Chih Hsu, Bin You, Yi-Lin Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2023
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung CancerDavid H Johnson, Louis Fehrenbacher, William F Novotny, et al.
Journal of Clinical Pathology|May 10, 2012
The expression of Dishevelled-3 and glutamine metabolism in malignant pleural mesotheliomaTong Li, Sheng-Cai Hou, Jian-Hua Mao, et al.
Journal of Cellular and Molecular Medicine|March 26, 2018
Inhibition of yes-associated protein suppresses brain metastasis of human lung adenocarcinoma in a murine modelPing-Chih Hsu, Jinbai Miao, Zhen Huang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 26, 2014
CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cellsShulin Zhang, Yi-Lin Yang, Yucheng Wang, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 1, 2013
Analytical validation of a practical molecular assay prognostic of survival in nonsquamous non-small cell lung cancerJohannes R Kratz, Patrick T Tham, Michael S Mulvihill, et al.
Pageof 20